Perspective Chapter: Sequelae and Consequences of COVID-19 in the Paediatric Population DOI Creative Commons
Víctor Manuel Gutiérrez Gómez,

Lenin Ortiz-Ortega,

Beatriz X. Pasco-Velázquez

et al.

IntechOpen eBooks, Journal Year: 2024, Volume and Issue: unknown

Published: Nov. 25, 2024

During the pandemic and in subsequent years, we observed that COVID-19 caused by SARS-CoV-2 virus affected paediatric population different ways. In certain groups of children adolescents, social isolation, changes family dynamics, increased exposure to technological screens diet, among others, have their development, education, emotional, physical aspects, including access immunizations, medical surveillance control. is considered a generally benign pathology children; however, some patients develop well-defined post-COVID-19 entities: multisystem inflammatory syndrome (MIS-C) long COVID. this chapter, review, relation population, effects confinement during its development consequences, forms clinical presentation entities MIS-C COVID, prevalence, pathophysiology, presentation, evolution, detection management recommendations.

Language: Английский

Alterations in microbiota of patients with COVID‐19: implications for therapeutic interventions DOI Creative Commons
Yong Qiu, Chunheng Mo, Lu Chen

et al.

MedComm, Journal Year: 2024, Volume and Issue: 5(4)

Published: March 15, 2024

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) recently caused a global pandemic, resulting in more than 702 million people being infected and over 6.9 deaths. Patients with disease (COVID-19) may suffer from diarrhea, sleep disorders, depression, even cognitive impairment, which is associated long COVID during recovery. However, there remains no consensus on effective treatment methods. Studies have found that patients COVID-19 alterations microbiota their metabolites, particularly the gut, be involved regulation of immune responses. Consumption probiotics alleviate discomfort by inflammation oxidative stress. pathophysiological process underlying alleviation COVID-19-related symptoms complications targeting unclear. In current study, we summarize latest research evidence together SARS-CoV-2 vaccine use, focus relationship between use. This work provides probiotic-based interventions improve regulating gut systemic immunity. Probiotics also used as adjuvants to efficacy.

Language: Английский

Citations

6
Alterations in Gut Microbiome Composition and Increased Inflammatory Markers in Post-COVID-19 Individuals DOI
Tatiana Barichello, Bruno Kluwe‐Schiavon, Laura A. Borba

et al.

Molecular Neurobiology, Journal Year: 2025, Volume and Issue: unknown

Published: Feb. 18, 2025

Language: Английский

Citations

0
Post-COVID Gut Dysbiosis and Its Role in Persistent Skin Disorders: A Gut–Skin Axis Perspective DOI Creative Commons
Dorra Guermazi,

Elias Guermazi

COVID, Journal Year: 2025, Volume and Issue: 5(4), P. 48 - 48

Published: March 31, 2025

The COVID-19 pandemic has led to persistent complications beyond the respiratory system, with emerging evidence highlighting role of gut dysbiosis in long COVID. Given established gut–skin axis, alterations microbiota post-COVID-19 may contribute dermatologic conditions such as eczema, acne, and rosacea. This review explores mechanisms by which SARS-CoV-2 disrupts microbiome, leading systemic inflammation skin disease. Furthermore, it examines potential interventions, including probiotics, prebiotics, dietary modifications, microbiome-targeted therapeutic strategies for post-COVID recovery. Understanding this link open new avenues treating chronic inflammatory COVID patients.

Language: Английский

Citations

0
The Interplay of Microbiota, Long COVID, and Musculoskeletal Pain: A Narrative Review DOI Creative Commons
Leila Simorgh, Rozita Hedayati,

Mina Sadat Mirshoja

et al.

Deleted Journal, Journal Year: 2024, Volume and Issue: 1(2)

Published: Sept. 1, 2024

Context: Long COVID, a condition that persists after the acute phase of COVID-19, poses significant burden, with 10 - 45% recovered patients experiencing persistent symptoms. Among these, approximately 46% report musculoskeletal pain. This narrative review explores potential connections between gut microbiota, and pain, aiming to introduce new therapeutic avenues preventive strategies for managing symptoms in COVID patients. Evidence Acquisition: A comprehensive search was conducted using Google Scholar, Lens.org, ConnectedPaper.com identify relevant articles published 2019 2024. Keywords related pain were used. Articles selected based on predefined inclusion exclusion criteria, their quality assessed. Data from synthesized provide an overview interplay Results: Recent research highlights role microbiota modulating immune responses systemic inflammation. Dysbiosis has been linked severity progression COVID-19 persistence Individuals often experience new-onset manifestations, such as joint myalgia, chronic Additionally, dysbiosis associated conditions like lower back knee osteoarthritis. suggests relationship problems general may also extend patients, indicating broader implications outcomes. Therapeutic targeting probiotics, prebiotics, dietary interventions, have shown promise these improving overall health Conclusions: The evidence underscores importance understanding microbiota-musculoskeletal nexus COVID. Gut contributes inflammation, exacerbating associations other emphasize need microbiota-targeted strategies. Future should focus elucidating mechanisms linking exploring gut-brain axis, developing personalized approaches modulate microbiota. Advancing our this can pave way innovative address complex challenges posed by conditions.

Language: Английский

Citations

0
Acute changes in hippocampal metabolism after anesthesia and surgery: Implications for perioperative neurocognitive disorder DOI
Yong Qiu, Chunheng Mo, Jiachen Li

et al.

Biochemical and Biophysical Research Communications, Journal Year: 2024, Volume and Issue: 736, P. 150492 - 150492

Published: Aug. 3, 2024

Language: Английский

Citations

0
Perspective Chapter: Sequelae and Consequences of COVID-19 in the Paediatric Population DOI Creative Commons
Víctor Manuel Gutiérrez Gómez,

Lenin Ortiz-Ortega,

Beatriz X. Pasco-Velázquez

et al.

IntechOpen eBooks, Journal Year: 2024, Volume and Issue: unknown

Published: Nov. 25, 2024

During the pandemic and in subsequent years, we observed that COVID-19 caused by SARS-CoV-2 virus affected paediatric population different ways. In certain groups of children adolescents, social isolation, changes family dynamics, increased exposure to technological screens diet, among others, have their development, education, emotional, physical aspects, including access immunizations, medical surveillance control. is considered a generally benign pathology children; however, some patients develop well-defined post-COVID-19 entities: multisystem inflammatory syndrome (MIS-C) long COVID. this chapter, review, relation population, effects confinement during its development consequences, forms clinical presentation entities MIS-C COVID, prevalence, pathophysiology, presentation, evolution, detection management recommendations.

Language: Английский

Citations

0